Tablet preparation
Tablets with a constant weight of 50 mg (4x4 mm) were prepared by the compression of a homogeneous mixture of excipients and FucCS as described below (Tables 1 and   2 ) using a manual hydraulic press equipped with a 5-mm diameter flat-faced punch. All punch pieces were disinfected with 70% ethanol before the preparation of each tablet. 
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Tablet evaluation
The gastro-resistant tablets prepared were evaluated for disintegration, tensile strength and friability according to the USP 30 (United States Pharmacopeia) and the Brazilian Pharmacopeia IV (1988).
In vitro drug release -pH change dissolution tests
In vitro drug release studies for the gastro-resistant coating formulations used in this study were conducted in accordance with the United Stated Pharmacopeia 30
standards (2007) and the Brazilian Pharmacopeia IV (1988) using a USP II apparatus (AT 7 Smart, SOTAX, Switzerland). Each experiment was carried out in triplicate in dissolution medium at 37°C with a paddle speed of 50 rpm. The tablets were tested in 750 mL of a stimulated gastric fluid (0.1 M HCl, pH 1.2) for 2 h, followed by 4 h of exposure to phosphate buffer, pH 6.8. The amount of released FucCS was determined at specific intervals based on the metachromasia produced by sulfated glycosaminoglycans in the presence of 1,9-dimethylmethylene blue and by hexuronic acid, using the carbazole reaction (16) to construct the calibration curve. The experiment was continued until the complete disintegration of the tablets.
The disintegration time of enteric coated tablets was evaluated according to the pharmacopeia standards (USP 30). A coating level was considered sufficient when the USP 30 criteria for the delayed release tablets were met (less than 10% of the drug after 2 h at pH 1.2, followed by the release of at least 80% of the tablet's payload within 45 min) (USP Convention, 2007) . As shown in Fig. S1 , the enteric-coated tablets containing FucCS met the pharmacopoeia requirements because no drug release was observed under highly acidic conditions and approximately 85% of the fucCS loaded was released in 45 min at pH 6.8.
Suppl. Figure 2:
In vitro fucosylated chondroitin sulfate released using the USP II pH change method (0.1 M HCl medium for 2 h followed by phosphate buffer for 4 h). The percentage of fucCS released into the medium was calculated using the metachromasia and carbazole reaction of the sulfated polysaccharide using a calibration curve. As shown in Suppl. Figure 3A , the anticoagulant activity of FucCS decreases after different periods of time of incubation in this medium. Blue, red, blue and green curves represent, respectively, the pattern of the anticoagulant activity of fucCS incubated for 0, 15, 60 and 120 min in the acidic medium. The numbers shown in the panel represent the values of anticoagulant activity in IU mg -1 compared to a standard sample. The anticoagulant activity of FucCS decreases 32% after 120 min of incubation in the acid medium (Fig S3B) .
2.4-Anticoagulant activity of fucosylated chondroitin sulfate submitted to acidic conditions
Suppl. create a more drastic condition to simulate possible alterations that may occur in a low degree in the gastric juice. We observed that the content of 2,4-and 3-sulfated fucose units (units A and C in Fig. S1 ) decreases after incubation in these conditions (Fig. S4 ).
Possibly, a similar effect occurs at a low extension on the acidic pH of the gastric juice.
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